The global head and neck cancer drugs market is estimated to be valued at US$ 1,851.2 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Head and neck cancer drugs are used for the treatment of head and neck cancer, which includes cancers of the mouth, throat, larynx, salivary glands, nose, and sinuses. These drugs play a crucial ... Read more

Market Overview
The head and neck cancer drugs market comprises drugs that are used for treating various types of cancers that develop in the head and neck regions such as oral cavity, nasopharynx, oropharynx, hypopharynx, and larynx. The increasing prevalence of head and neck cancers, rising uptake of targeted therapies, and growing pipeline of novel therapeutic molecules are the key factors driving the growth of the market. Head and neck cancers are the sixth most ... Read more